Monday - April 21, 2025
Client Xilio Therapeutics Enters Collaboration With AbbVie to Develop Novel T Cell Therapies Worth Up to $2.1 Billion
February 14, 2025
BOSTON, Massachusetts, Feb. 14 -- Ropes and Gray, a law firm, issued the following news:

* * *

Client Xilio Therapeutics Enters Collaboration with AbbVie to Develop Novel T Cell Therapies Worth Up to $2.1 Billion

Ropes & Gray advised Xilio Therapeutics in a strategic collaboration and option agreement with AbbVie to discover and develop tumor-activated immunotherapies, including masked T cell engagers, in a deal worth up to $2.1 billion.

T . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products